CompletedNCT02670551
This study is completed in the United States, in Bulgaria, in Estonia, .... It focuses on depression.
Multiple locations, including Little RockBipolarity, DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States, Bulgaria, Estonia, ...
- Sponsor
- Forest Laboratories
- Condition
- Bipolarity, Depression
CompletedNCT05956483
This study is completed in the United States. It is testing accuracy of Rapid Mood Screener for depression.
Multiple locations, including Costa MesaBipolarity, DepressionOtherOver 18 Years
- Countries
- United States
- Sponsor
- AbbVie
- Condition
- Bipolarity, Depression
CompletedNCT00501865
This study is completed in the United Kingdom. It is testing Effect of Food on the Concentration of GW273225 for Bipolarity.
In CambridgeBipolarityOtherFrom 18 Years to 55 Years
- Countries
- United Kingdom
- Sponsor
- GlaxoSmithKline
- Condition
- Bipolarity
CompletedNCT02184767
This study is completed in the United States. 5, 5, or 10 mg for Bipolarity.
Multiple locations, including AtlantaBipolarityOtherFrom 10 Years to 17 Years
- Countries
- United States
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Condition
- Bipolarity
CompletedNCT00399698
This study is completed in the United States. It focuses on ADHD.
In ColumbusADHD, BipolarityOtherFrom 4 Years to 14 Years
- Countries
- United States
- Sponsor
- Ohio State University
- Condition
- ADHD, Bipolarity
CompletedNCT02362412
This study is completed in Japan. It is testing Effects of Switching Different Strength Forms of FK949E for depression.
Multiple locations, including FukushimaDepression, BipolarityOtherFrom 20 Years to 64 Years
- Countries
- Japan
- Sponsor
- Astellas Pharma Inc
- Condition
- Depression, Bipolarity
CompletedNCT01305408
This study is completed in the United States, in Argentina, in Brazil, .... It is testing Armodafinil Treatment (150 mg/Day) for depression.
Multiple locations, including BirminghamBipolarity, DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States, Argentina, Brazil, ...
- Sponsor
- Cephalon
- Condition
- Bipolarity, Depression
CompletedNCT01072630
This study is completed in the United States, in Australia, in France, .... It is testing armodafinil Treatment for depression.
Multiple locations, including BirminghamBipolarity, DepressionOtherFrom 18 Years to 65 Years
- Countries
- United States, Australia, France, ...
- Sponsor
- Cephalon
- Condition
- Bipolarity, Depression
CompletedNCT03187769
This study is completed in the United States, in the United Kingdom, in Austria, .... It is testing Efficacy of ALKS 3831 on Body Weight for schizophrenia.
Multiple locations, including Little RockBipolarity, SchizophreniaOtherFrom 16 Years to 40 Years
- Countries
- United States, United Kingdom, Austria, ...
- Sponsor
- Alkermes, Inc.
- Condition
- Bipolarity, Schizophrenia
CompletedNCT03201757
This study is completed in the United States, in the United Kingdom, in Austria, .... It focuses on Schizophrenia.
Multiple locations, including Little RockSchizophrenia, BipolarityOtherFrom 16 Years to 70 Years
- Countries
- United States, United Kingdom, Austria, ...
- Sponsor
- Alkermes, Inc.
- Condition
- Schizophrenia, Bipolarity
CompletedNCT02738944
This study is completed. It focuses on PTSD and currently lists study information in the United States.
Multiple locations, including MariannaPTSD, BipolarityOtherOver 18 Years
- Countries
- United States
- Sponsor
- University of Washington
- Condition
- PTSD, Bipolarity
CompletedNCT01409096
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In DallasBipolarity, DepressionOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
- Condition
- Bipolarity, Depression